BioSpace News Archive

The annual general meeting in Orexo AB (publ) on 12 April 2018 resolved, in accordance with the nomination committee’s proposal, that the number of board members shall be seven with no deputy board members.

The Company’s Stem Cell Therapies to be Main Subject at Dr. James Veltmeyer’s Congressional Health Care Symposium

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) today announced that the Arbitral Tribunal issued a decision (rendered on April 9, 2018) relating to the arbitration between Santarus Inc. and Valeant Pharmaceuticals Ireland (collectively “Valeant”), and Cosmo Technologies Ltd. and Cosmo Technologies III Ltd. (collectively, “Cosmo”), the licensor of certain intellectual property rights in, and supplier of, Valeant’s UCERIS® extended release tablets.

Acquisition adds real-world effectiveness prediction and value assessment to Certara’s model-informed drug development and regulatory science decision-making portfolio

Regional Health Properties, Inc. announced that it plans to release its fourth quarter and year end 2017 financial results on Friday, April 13, 2018 after the market close.

Pharnext SA reported its financial and operational results for the year ended December 31, 2017.

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative therapeutics for dogs and cats, will host a live conference call on Friday, May 4, 2018 at 8:30 a.m. ET to discuss financial results from the first quarter ended March 31, 2018.

HBI Solutions has partnered with the Koble Group to make HBI’s leading risk management software accessible for participants of Koble Group’s health information exchange.

GEOS is taking healthcare safety in a new direction, by integrating campus and remote site safety into one proactive solution.

Global organization calls for urgent investment as famine prevention funding stalls